Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTKB | ABCL | ERAS | ||
| Company | Cytek Biosciences Inc | Abcellera Biologics Inc | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.09 | 2.69 | 2.77 | ||
| High | 6.30 | 2.71 | 2.82 | ||
| Low | 5.99 | 2.64 | 2.70 | ||
| Last | 6.03 | 2.64 | 2.70 | ||
| Change | -0.10 | -0.07 | -0.09 | ||
| % Change | -1.63% | -2.58% | -3.23% | ||
| Volume | 78,093 | 81,780 | 43,548 | ||
| 20-Day Average Volume | 897,133 | 2,569,531 | 1,679,398 | ||
| Previous Close | 6.13 | 2.71 | 2.79 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.90 | 2.78 | 2.83 | ||
| 20-Day Raw Stochastic | 47.47% | 27.94% | 33.53% | ||
| 20-Day Relative Strength | 53.79% | 48.65% | 47.98% | ||
| Weighted Alpha | -25.64 | -41.05 | +2.92 | ||
| Today's Opinion | 8% Buy | 40% Sell | 40% Buy | ||
| Previous Opinion | 24% Buy | 40% Sell | 64% Buy | ||
| Last Month's Opinion | 100% Sell | 48% Sell | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.47% since 11/13/24 | -7.88% since 11/13/24 | -4.21% since 11/13/24 | ||
| Low | 5.68 on 11/19/24 | 2.57 on 11/15/24 | 2.62 on 11/15/24 | ||
| High | 6.78 on 11/14/24 | 2.97 on 11/14/24 | 2.97 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | +17.41% since 10/18/24 | -6.27% since 10/18/24 | -6.19% since 10/18/24 | ||
| Low | 4.66 on 10/25/24 | 2.50 on 11/05/24 | 2.44 on 10/28/24 | ||
| High | 7.63 on 11/07/24 | 3.18 on 11/11/24 | 3.31 on 11/07/24 | ||
| 3-Month | |||||
| %Chg | +14.31% since 08/20/24 | +3.46% since 08/20/24 | -1.44% since 08/20/24 | ||
| Low | 4.66 on 10/25/24 | 2.34 on 09/10/24 | 2.41 on 10/08/24 | ||
| High | 7.63 on 11/07/24 | 3.18 on 11/11/24 | 3.31 on 11/07/24 | ||
| 6-Month | |||||
| %Chg | +1.85% since 05/20/24 | -28.07% since 05/20/24 | +21.88% since 05/20/24 | ||
| Low | 4.66 on 10/25/24 | 2.34 on 09/10/24 | 1.96 on 06/18/24 | ||
| High | 7.63 on 11/07/24 | 4.34 on 05/28/24 | 3.45 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 789,612 | 800,442 | 788,808 | ||
| Shares Outstanding, K | 128,811 | 295,366 | 282,727 | ||
| Annual Sales | 193,020,000 | 38,030,000 | 0 | ||
| Annual Net Income | -12,150,000 | -146,400,000 | -125,040,000 | ||
| Last Quarter Sales | 51,500,000 | 6,510,000 | 0 | ||
| Last Quarter Net Income | 940,000 | -51,110,000 | -31,200,000 | ||
| 60-Month Beta | 1.32 | 0.35 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 11/05/24 | -0.17 on 11/04/24 | -0.11 on 11/12/24 | ||
| Latest Earnings Date | 11/05/24 | 11/04/24 | 11/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||